You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫藥數智化板塊集體上漲,美年健康漲超3%,七部門發文鼓勵開展“人工智能賦能醫藥全產業鏈”應用試點
A股市場醫藥數智化板塊集體上漲,其中,思創醫惠漲超13%,創業慧康漲超7%,朗瑪信息、衛寧健康漲超5%,潤達醫療、寶萊特、陽普醫療漲超4%,迪安診斷、華平股份、美年健康、東華軟件、萬達信息、嘉和美康漲超3%。消息面上,七部門印發《醫藥工業數智化轉型實施方案(2025-2030年)》提出,深化人工智能賦能應用。支持相關單位建立醫藥大模型創新平臺,協同開展醫藥大模型技術產品研發、監管科學研究等,強化標準規範、科技倫理、應用安全和風險管理等規則建設。開展“人工智能賦能醫藥全產業鏈”應用試點,鼓勵龍頭醫藥企業與醫療機構、科研院所、上下遊企業、大用戶等組成聯合體,面向醫藥全產業鏈形成一批效果顯著的標誌性應用場景。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account